StockData
Novartis AG logo

Novartis AG (NVS) stock

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.20−0.30 (-0.19%)

Close on Nov 16, 2026Market cap $305.69BP/E 22.4Yield –

Novartis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Novartis's pe ratio was 22.8× on Nov 10, 2026, against 22.2× a year earlier. Over the last 5 years it ranged from 7.2× to 33.1×, with a median of 20.7×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 202622.8×−0.7
2025Dec 31, 202523.5×+9.8
2024Dec 31, 202413.7×−18.1
2023Dec 29, 202331.9×+23.3
2022Dec 30, 20228.5×−16.3
2021Dec 31, 202124.8×+6.2
2020Dec 31, 202018.7×+1.1
2019Dec 31, 201917.6×−8.8
2018Dec 31, 201826.4×−3.6
2017Dec 29, 201730.0×+20.0
2016Dec 30, 201610.0×–

More Novartis figures

See a number that looks wrong?